Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trualt Bioenergy's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 59.11.
Trualt Bioenergy's Days Inventory for the
three
months ended in Jun. 2026 was 115.74.
Trualt Bioenergy's Days Payable for the
three
months ended in Jun. 2026 was 59.6.
Therefore, Trualt Bioenergy's Cash Conversion Cycle (CCC) for the
three
months ended in Jun. 2026 was 115.25.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Trualt Bioenergy Cash Conversion Cycle Related Terms
Trualt Bioenergy Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Trualt Bioenergy's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544545 vs MPC, VLO, PSX: Cash Conversion Cycle Comparison
For the Oil & Gas Refining & Marketing subindustry, Trualt Bioenergy's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trualt Bioenergy Cash Conversion Cycle vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Trualt Bioenergy's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Trualt Bioenergy's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Trualt Bioenergy's Cash Conversion Cycle for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trualt Bioenergy (BOM:544545) has a Cash Conversion Cycle of 115.25 as of Jun. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Trualt Bioenergy and its competitors.
Is Trualt Bioenergy's Cash Conversion Cycle too high?
Trualt Bioenergy's current Cash Conversion Cycle is 115.25. The Oil & Gas industry median Cash Conversion Cycle is 18.24. Trualt Bioenergy's value of 115.25 is 532% above this industry median. Overall, Trualt Bioenergy has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Trualt Bioenergy's Cash Conversion Cycle compare to MPC and VLO?
Trualt Bioenergy's Cash Conversion Cycle of 115.25 can be compared against companies in the Oil & Gas industry. The industry median Cash Conversion Cycle is 18.24. Trualt Bioenergy's value of 115.25 is 532% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for an Oil & Gas company?
The median Cash Conversion Cycle among Oil & Gas companies is 18.24, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trualt Bioenergy's current Cash Conversion Cycle of 115.25 is 532% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Trualt Bioenergy and its competitors. For the Oil & Gas industry, the median Cash Conversion Cycle is 18.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trualt Bioenergy's current Cash Conversion Cycle is 115.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trualt Bioenergy stock overvalued right now?
Trualt Bioenergy (BOM:544545) has a current Cash Conversion Cycle of 115.25. The current Cash Conversion Cycle is 115.25 and 532% above the Oil & Gas industry median of 18.24. Trualt Bioenergy's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Trualt Bioenergy (BOM:544545), the current Cash Conversion Cycle is 115.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Trualt Bioenergy Ltd is a biofuels producer, particularly in the Ethanol sector. As part of its Ethanol production, the company also produces extra neutral alcohol (ENA), the raw material in the production of alcoholic beverages. Its product portfolio also includes dry ice and liquid carbon dioxide (CO2), by-products in the Ethanol production process. The group is engaged in the business of manufacturing, selling ethanol and compressed biogas, and other products derived from distillery processes.
42GF Score
Get the complete analysis for BOM:544545
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544545 has been successfully added to your 
